Psychosocial stress and ovarian function in adolescent and young adult cancer survivors.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
25 01 2021
Historique:
received: 03 08 2020
revised: 27 09 2020
pubmed: 7 12 2020
medline: 26 5 2021
entrez: 6 12 2020
Statut: ppublish

Résumé

Is psychosocial stress associated with ovarian function in reproductive-aged survivors of cancer diagnosed as adolescents and young adults (AYA survivors)? We observed no association between self-reported and biomarkers of psychosocial stress and ovarian function in AYA survivors. Psychosocial stress suppresses hypothalamic-pituitary-ovarian axis, resulting in ovulatory dysfunction, decreased sex steroidogenesis and lower fertility in reproductive-aged women. Many cancer survivors experience high psychosocial stress and hypothalamic-pituitary-adrenal axis dysregulation. The menstrual pattern disturbances and infertility they experience have been attributed to ovarian follicle destruction, but the contribution of psychosocial stress to these phenotypes is unknown. A cross-sectional study was conducted estimating the association between perceived stress, measured by self-report and saliva cortisol, and ovarian function, measured by bleeding pattern, dried blood spot (DBS) FSH and LH, and saliva estradiol. We included 377 AYA survivor participants. AYA survivor participants were ages 15-35 at cancer diagnosis and ages 18-40 at study enrollment, had completed primary cancer treatment, had a uterus and at least one ovary, did not have uncontrolled endocrinopathy and were not on hormone therapy. Recruited from cancer registries, physician referrals and cancer advocacy groups, participants provided self-reported information on psychosocial stress (Perceived Stress Scale-10 (PSS-10)) and on cancer and reproductive (fertility, contraception, menstrual pattern) characteristics. DBS samples were collected timed to the early follicular phase (cycle Days 3-7) for menstruating individuals and on a random day for amenorrheic individuals; saliva samples were collected three time points within 1 day. FSH and LH were measured by DBS ELISAs, cortisol was measured by ELISA and estradiol was measured by liquid chromatography tandem mass spectrometry. The median age of participants was 34.0 years (range 19-41) at a median of 6.0 years since cancer diagnosis. The most common cancer was breast (32.1%). Median PSS-10 score was 15 (range 0-36), with 5.3% scoring ≥26, the cut point suggestive of severe stress. Cortisol levels followed a diurnal pattern and cortisol AUC was negatively correlated with PSS-10 scores (P = 0.03). Neither PSS-10 scores nor cortisol AUC were associated with FSH, LH, estradiol levels or menstrual pattern. Waking and evening cortisol and the cortisol awakening response also were not related to ovarian function measures. Our analysis is limited by its cross-sectional nature, heterogeneity of cancer diagnosis and treatments and low prevalence of severe stress. The lack of association between psychosocial stress and a variety of ovarian function measures in female AYA cancer survivors suggests that psychosocial stress does not have a significant impact on the reproductive axis of AYA survivors. This finding is important in counseling this population on their menstrual pattern and family building plans. NIH HD080952, South Korea Health Industry Development Institute HI18C1837 (JK). Dr A.D. works for Bluebird Bio, Inc., Dr D.Z. works for ZRT Labs and Dr P.M.S. works for Ansh Labs, which did not sponsor, support or have oversight of this research. Other authors report no competing interests. N/A.

Identifiants

pubmed: 33279981
pii: 6024831
doi: 10.1093/humrep/deaa313
pmc: PMC7829546
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-414

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD080952
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Fertil Steril. 2005 Jun;83(6):1745-52
pubmed: 15950646
Am J Epidemiol. 2016 Aug 1;184(3):199-210
pubmed: 27407085
J Psychosom Obstet Gynaecol. 2010 Sep;31(3):130-9
pubmed: 20718584
Neurobiol Stress. 2015 Apr 30;2:34-43
pubmed: 26844238
Epidemiology. 2019 Nov;30 Suppl 2:S76-S84
pubmed: 31569156
Minerva Endocrinol. 2010 Jun;35(2):109-25
pubmed: 20595939
Endocrinology. 2013 Dec;154(12):4450-68
pubmed: 24064362
Hum Reprod. 1998 Aug;13(8):2296-300
pubmed: 9756314
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):17058-63
pubmed: 17075058
Hum Reprod. 2019 Sep 29;34(9):1674-1685
pubmed: 31411325
Eur J Cancer Care (Engl). 2012 Jan;21(1):52-8
pubmed: 21883564
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32270202
Am J Phys Anthropol. 1997 Sep;104(1):1-21
pubmed: 9331450
Clin Endocrinol (Oxf). 1993 Jun;38(6):641-4
pubmed: 8334750
Hum Reprod. 2014 May;29(5):1067-75
pubmed: 24664130
Anim Reprod Sci. 2012 Feb;130(3-4):135-40
pubmed: 22325927
Stress. 2020 May;23(3):275-283
pubmed: 31578916
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Oncol Nurs Forum. 2019 May 1;46(3):E75-E85
pubmed: 31007257
Arch Intern Med. 1997 Feb 10;157(3):309-14
pubmed: 9040298
Psychosom Med. 2005 Mar-Apr;67(2):277-80
pubmed: 15784794
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:69-76
pubmed: 23969030
Mol Cell Endocrinol. 2014 Mar 25;385(1-2):71-7
pubmed: 24012628
Vital Health Stat 1. 2009 Sep;(48):1-64
pubmed: 20141029
Anal Chem. 2015 Jul 21;87(14):7180-6
pubmed: 26090565
J Clin Oncol. 2006 Mar 1;24(7):1045-51
pubmed: 16476708
Am J Hum Biol. 2004 Sep-Oct;16(5):523-32
pubmed: 15368600
Adv Exp Med Biol. 2015;872:253-78
pubmed: 26215998
Lancet Oncol. 2013 Aug;14(9):873-81
pubmed: 23856401
J Clin Oncol. 2009 May 10;27(14):2319-27
pubmed: 19364957
Epidemiology. 2015 Mar;26(2):177-84
pubmed: 25643098
Clin Chem. 1994 Mar;40(3):448-53
pubmed: 8131281
Psychoneuroendocrinology. 2017 Sep;83:25-41
pubmed: 28578301
Phys Ther. 2014 Dec;94(12):1816-25
pubmed: 25035267
Am J Hum Biol. 2011 Sep-Oct;23(5):609-20
pubmed: 21638512
Bone Marrow Transplant. 2015 Dec;50(12):1551-6
pubmed: 26237168
Psychosom Med. 2004 Mar-Apr;66(2):207-14
pubmed: 15039505
BMJ Open. 2018 Feb 24;8(2):e018323
pubmed: 29478014
J Clin Oncol. 2009 May 10;27(14):2396-404
pubmed: 19255309
Psychoneuroendocrinology. 2017 Oct;84:139-142
pubmed: 28711723
Fertil Steril. 2005 Feb;83(2):383-92
pubmed: 15705379
J Womens Health (Larchmt). 2005 Dec;14(10):929-35
pubmed: 16372894
J Cancer Surviv. 2014 Jun;8(2):293-303
pubmed: 24459073

Auteurs

Jayeon Kim (J)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, CHA Seoul Fertility Center, CHA University, Seoul, Republic of Korea.

Brian W Whitcomb (BW)

Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst.

Brian Kwan (B)

Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health and Moores Cancer Center, University of California, San Diego.

David Zava (D)

ZRT Laboratory.

Andrew Dietz (A)

Moores Cancer Center, University of California, San Diego.
Bluebird Bio, Inc.

Ksenya Shliakhtsitsava (K)

Division of Pediatric Hematology and Oncology, University of Texas Southwestern.

Sally A D Romero (SAD)

Department of Family Medicine and Public Health and Moores Cancer Center, University of California, San Diego.

Loki Natarajan (L)

Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health and Moores Cancer Center, University of California, San Diego.

H Irene Su (HI)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences and Moores Cancer Center, University of California, San Diego.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH